-transparent.png){kind=logo}
The development of bronchial hyperresponsiveness (BHR) in asthma is considered to be caused by inflammation of the airway. In IgE-mediated allergy BHR is related to the occurrence of late phase reactions. We have previously shown that exposure to low doses of allergen can cause isolated late reactions. These findings are potentially of clinical importance, since exposure to low, subclinical allergen doses may lead to bronchial inflammation and increasing bronchial responsiveness without necessarily causing immediate bronchoconstriction. This study was performed to investigate whether repeated exposure to low doses of allergen could induce a change in BHR. The trial comprised two groups of five and eight patients with a history of allergic asthma. They were submitted to a series of allergen inhalations for 5-7 days. They were given the same low allergen dose (1-10 biological units) each day. Before and after the allergen exposure period histamine challenges were performed. After the week of allergen inhalation the bronchial responsiveness was increased in 11 of 13 patients.
E Ihre, and
O Zetterström
October 1999,
International archives of allergy and immunology,
E Ihre, and
O Zetterström
February 2011,
Journal of aerosol medicine and pulmonary drug delivery,
E Ihre, and
O Zetterström
November 1977,
Clinical allergy,
E Ihre, and
O Zetterström
December 1988,
The American review of respiratory disease,
E Ihre, and
O Zetterström
August 2006,
American journal of respiratory cell and molecular biology,
E Ihre, and
O Zetterström
May 1996,
Thorax,
E Ihre, and
O Zetterström
July 1994,
Respiratory medicine,
E Ihre, and
O Zetterström
October 1994,
American journal of respiratory and critical care medicine,
E Ihre, and
O Zetterström
January 1997,
Pneumonologia i alergologia polska,
E Ihre, and
O Zetterström
January 1987,
Vutreshni bolesti,
